WuXi Biologics Opens Expanded $150 Million Biomanufacturing Facility

WuXi Biologics has completed construction of its $150 million 30,000 liter biomanufacturing facility in China . The CRO/CMO initially announced it would build the facility in April 2015. Completed in two stages, the plant has begun operating fourteen 2,000 liter disposable bioreactors for fed-batch cell culture in the facility, the second construction phase, greatly expanding Phase I capacity, which consisted of two 1000 liter disposable bioreactors. WuXi Biologics' plant, located in Wuxi city offers cGMP contract manufacturing services for biologic drugs to WuXi clients. More details.... Stock Symbol: (HK: 2269) Share this with colleagues: // //